Proangiogenic Cyclic Peptide Nanotubes for Diabetic Wound Healing

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Biochemistry

Background:

• Chronic wounds, like diabetic foot ulcers, exhibit poor angiogenesis, hindering healing.
• Current therapies for promoting angiogenesis face challenges like poor stability and immunogenicity.
• Heparan sulfate (HS) is crucial for growth factor signaling but difficult to administer exogenously.

Purpose of the Study:

• To develop novel heparan sulfate (HS)-mimetic cyclic peptide nanotubes (CPNTs) for enhancing angiogenesis.
• To investigate the proangiogenic potential of these CPNTs in hyperglycemic conditions.
• To assess the efficacy of CPNTs as a therapeutic strategy for diabetic wound healing without exogenous growth factors.

Main Methods:

• Synthesized sulfonated cyclic hexapeptide nanotubes mimicking heparan sulfate functional groups.
• Incorporated glutamic acid, serine, and sulfonated lysine into the peptide structure.
• Evaluated the proangiogenic activity of CPNTs using human umbilical vein endothelial cells (HUVECs) under hyperglycemic conditions.

Main Results:

• Developed CPNTs demonstrated significant proangiogenic activity in HUVECs.
• CPNTs enhanced endothelial cell motility, invasion, and tube formation.
• Upregulation of key proangiogenic genes and proteins was observed, indicating effective signaling.

Conclusions:

• Heparan sulfate-mimetic cyclic peptide nanotubes show strong potential for promoting impaired angiogenesis.
• These novel nanotubes offer a promising, growth factor-free approach for treating diabetic wounds.
• This study represents the first report on HS-mimetic proangiogenic cyclic peptide nanotubes for diabetic wound healing.